1. Sézary A, Bouvrain Y. Erythrodermic avec presence de cellules monstreuses dans le derme at le sang circulant. Bull Soc Fr Dermatol Syphiligr. 1938;45:254-260.
2. Taswell HF, Winkelmann RK. Sézary syndrome: a malignant reticulemic erythroderma. JAMA. 1961;177:465-472.
3. Lutzner MA, Jordan HW. The ultrastructure of an abnormal cell in Sézary's syndrome. Blood. 1968;31:719-726.
4. Bernengo MG, Quaglino P, Novelli M, et al. Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features. Ann Oncol. 1998;9:857-863.
5. Scarisbrick JJ, Whittaker S, Evans AV, et al. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma. Blood. 2001;97:624-630.